Daily News

Most Recent

Giants and men

By | May 1, 2009

A new book explores the many textures of African elephants


Take our 2009 salary survey

By | April 30, 2009

Help us compile the most current salary data for life scientists



By | April 17, 2009

How biology is central to constructing a more complete and unified theory of the Universe


Hip hop Darwin

By | April 17, 2009

The 19th century scientist that changed our understanding of biology gets a modern day makeover

1 Comment

The hype of science

By | April 15, 2009

Leading journals including Science and Nature are exaggerating research novelty


What a tangled web we weave

By | April 10, 2009

Understanding unethical behavior through genetics, biology and evolution


Southbound genes

By | April 8, 2009

A genome study in monarch butterflies pulls out a set of 40 key players in long distance migration

1 Comment


By | April 2, 2009

Will robots one day replace human scientists at lab benches?


Weaving glass

By | March 27, 2009

Two former scientists developed a revolutionary method for constructing glass sculptures


Dishing dirt

By | March 20, 2009

In new book, an immunologist explains why an intimate connection to the earth beneath our feet can keep us healthy


Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham